EXPERIENCE OF USING ALFLUTOP IN PATIENTS WITH OSTEOARTHRITIS

Abstract

In the conditions of an evaluation of the clinical efficiency and safety of alflutop - corrector metabolism of bone and
cartilage tissue by intramuscular (in/m) introduction of 15 patients with osteoarthritis. Were carried out on two courses of
treatment with alflutop 20-21 injection in/m during the year at 1 ml/day. All patients noted the good tolerance of the drug,
reducing pain and improving functional ability of the patient to the middle of the course of treatment. Hondroprotektiv effect of
the drug was shown after the full course of treatment and is saved in the course of 4-6 months. Аlflutop is indicated to
patients with osteoarthritis who need pain and anti-inflammatory therapy and wider application in the practice of physicians of
various specialties.